First Time Loading...
S

Shandong Pharmaceutical Glass Co Ltd
SSE:600529

Watchlist Manager
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Watchlist
Price: 28.8 CNY 1.02% Market Closed
Updated: Apr 29, 2024

Shandong Pharmaceutical Glass Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shandong Pharmaceutical Glass Co Ltd
Operating Income Peer Comparison

Comparables:
1066
603658
300888
300832
300595

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
S
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Operating Income
¥814.7m
CAGR 3-Years
9%
CAGR 5-Years
18%
CAGR 10-Years
17%
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Operating Income
¥2.6B
CAGR 3-Years
-2%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Autobio Diagnostics Co Ltd
SSE:603658
Operating Income
¥1.2B
CAGR 3-Years
11%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Operating Income
¥1.8B
CAGR 3-Years
45%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Operating Income
¥1.8B
CAGR 3-Years
20%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Autek China Inc
SZSE:300595
Operating Income
¥747.4m
CAGR 3-Years
21%
CAGR 5-Years
28%
CAGR 10-Years
N/A

See Also

What is Shandong Pharmaceutical Glass Co Ltd's Operating Income?
Operating Income
814.7m CNY

Based on the financial report for Sep 30, 2023, Shandong Pharmaceutical Glass Co Ltd's Operating Income amounts to 814.7m CNY.

What is Shandong Pharmaceutical Glass Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
17%

Over the last year, the Operating Income growth was 21%. The average annual Operating Income growth rates for Shandong Pharmaceutical Glass Co Ltd have been 9% over the past three years , 18% over the past five years , and 17% over the past ten years .